Derivative exercise or conversion — not an open-market buy.
Loading…
Traded Nov 21, 2025 · Filed Nov 25, 2025
Travelers's Vice Chairman sold $291K of Travelers shares. Nobody planned it ahead of time.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$291,000
Shares × reported transaction price
36 days after results of Oct 16, 2025, 61 days before results of Jan 21, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $290.07 on Nov 21, 2025, at its 52-week high, after a 7% rise over the previous 30 trading days
52-week range $232.43 (Jan 10, 2025) to $290.07 (Nov 21, 2025), 100% of the way up, from 250 adjusted closes. 30 trading days earlier: $270.12 on Oct 10, 2025. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −1.8% | +1.0% | −2.7% |
| 30 days | −0.5% | +2.3% | −2.8% |
| 90 days | +4.0% | +1.1% | +2.9% |
| 180 days | +3.8% | +11.2% | −7.4% |
Past results only. Not a forecast.
Derivative exercise or conversion — not an open-market buy.
Travelers's Strat Dev & Pres Intl sold $2.64M of Travelers shares. Nobody planned it ahead of time.
Derivative exercise or conversion — not an open-market buy.